This topic contains a solution. Click here to go to the answer

Author Question: A patient about to start systemic antifungal therapy has a white blood cell (WBC) count of 3200 ... (Read 95 times)

burchfield96

  • Hero Member
  • *****
  • Posts: 610
A patient about to start systemic antifungal therapy has a white blood cell (WBC) count of 3200 cells/mm3. Which antifungal drug must be avoided for this patient?
 
  a. Fluconazole (Diflucan)
  b. Ketoconazole (Nizoral)
  c. Micafungin (Mycamine)
  d. Terbinafine (Lamisil)

Question 2

A patient taking ketoconazole (Nizoral) for the last 2 weeks has all of the following blood laboratory test values. Which value should you report to the prescriber immediately?
 
  a. White blood cell count (WBC) 10,500 cells/mm3
  b. Lactate dehydrogenase 880 IU/L
  c. Potassium 3.6 mEq/L
  d. Hematocrit 32



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blfontai

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

ANS: D

Answer to Question 2

ANS: B




burchfield96

  • Member
  • Posts: 610
Reply 2 on: Jul 23, 2018
Excellent


Liddy

  • Member
  • Posts: 342
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library